Shenzhen Force of Life Science Co.
Latest round
- Series A
Last raised
- Oct 2019
Total raised
- $18M
Investors
- 2
About Shenzhen Force of Life Science Co.
, Ltd. operates as a developer of new drugs that focuses on the production and development of oncology drugs., and the CMO, Johannes Nippgen was the Head of R&D, Merck Pharma R&D, China. The company develops targeted and immunotherapies for more effective cancer treatment. The company develops tumor-targeted drugs and tumor immunomodulatory drugs designed to provide solutions to oncology, immunity, and cardiac metabolic diseases. The company's research wing, Touchstone Translational Research Institute, enables the company to establish both internal disease biology-driven drug discovery programs.
Who invested in Shenzhen Force of Life Science Co.
2 investors across 1 round
See all investors in Shenzhen Force of Life Science Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 15, 2019
Amount
$18M
Investors
Questions about Shenzhen Force of Life Science Co.
Who invested in Shenzhen Force of Life Science Co.?
Shenzhen Force of Life Science Co. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shenzhen Force of Life Science Co. raised?
Shenzhen Force of Life Science Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Shenzhen Force of Life Science Co. last raise money?
Shenzhen Force of Life Science Co.'s most recent round on record is a Series A, in Oct 2019.
What does Shenzhen Force of Life Science Co. do?
Shenzhen Force of Life Science Co. is a pharmaceuticals company.
Where is Shenzhen Force of Life Science Co. headquartered?
Shenzhen Force of Life Science Co. is headquartered in Shenzhen, China.
Which VCs invest in companies like Shenzhen Force of Life Science Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Shenzhen Force of Life Science Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Shenzhen Force of Life Science Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.